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Objective: To evaluate a new whole blood serology test 
(Hp Chek; ChemTrak) that detects IgG antibodies to 
Helicobacter pylori. Methods: The study was conducted 
at 10 sites within the United States. Patients undergoing 
upper endoscopy for dyspepsia were recruited for en- 
rollment. Those treated for H. pylon’ infection within a 
year of endoscopy and those who had regularly used 
proton pump inhibitors, bismuth compounds, or antibi- 
otics within a month of endoscopy were not eligible. 
During endoscopy, specimens were obtained from the 
corpus and antrum for histological examination, which 
was performed by a single experienced pathologist. The 
Hp Chek was tested using whole blood and serum. Se- 
rum was also tested with a reference enzyme-linked 
immunosorbent assay (ELISA) at a centralized location. 
Test characteristics for the Hp Chek and ELISA were 
calculated using histology as the “gold standard.” Re- 
sults: Two hundred eighty-seven patients (140 women 
and 147 men; mean age 53 + 6 yr) were enrolled. The Hp 
Chek was easy to perform and yielded results 9 min after 
inoculation of the test cassette with whole blood or se- 
rum. When the Hp Chek used with whole blood was 
compared with histology as the gold standard, the sen- 
sitivity was 88%, specificity 85%. positive predictive 
value 83%, negative predictive value 90%, and percent 
agreement 86%. There were no statistically significant 
differences among the results obtained with the Hp Chek 
using whole blood, the Hp Chek using serum, or refer- 
ence ELISA. Conclusions: The Hp Chek whole blood 
serology test was easy to perform and rapid and yielded 
performance characteristics comparable to those of a 
reference ELISA or the Hp Chek used with serum. (Am 
J Gastroenterol 1998;93:16-19. 0 1998 by Am. Coil. of 
Gastroenterology) 
INTRODUCTION 
Diagnostic tests for Helicohacter pylori can be divided 
into those that require endoscopy with gastric mucosal bi- 
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opsy (rapid urease testing, histology, culture) and those that 
can be performed independently of endoscopy (serology, 
urea breath testing) (1). Serology is currently the most 
cost-effective means of testing for H. p$ori infection (1). 
The role of H. pylori infection in the pathogenesis of dys- 
peptic symptoms in patients with no evidence of peptic ulcer 
disease remains poorly defined (2). However, preliminary 
work using decision analytical modeling suggested that it 
may be cost-effective to treat patients for H. pylori infection 
without evaluation with upper endoscopy (3). For this rea- 
son, it is anticipated that serology testing will become in- 
creasingly important in the management of dyspeptic pa- 
tients, particularly in the primary care setting (4). 
The majority of currently available serology tests for H. 
pylori rely upon the identification of specific immunoglob- 
ulin G (IgG) antibodies that can be found in saliva (5) and 
blood (6). Tests for the serodiagnosis of H. pylori in blood 
can be classified as quantitative (enzyme-linked immu- 
nosorbent assay [ELBA]) or qualitative. A number of qual- 
itative tests that are easy to perform and inexpensive are 
now commercially available (7, 8). These tests were origi- 
nally developed for use with serum, but recently, several 
companies have introduced products intended for use with 
whole blood. Unfortunately, the sensitivity of the current 
generation of whole blood serology tests has been inconsis- 
tent (9-12). 
We conducted a multicenter trial to evaluate the test 
characteristics of a new whole blood serology test manu- 
factured by ChemTrak (Hp Chek, formerly the “Accume- 
ter”; Sunnyvale. CA). Results obtained with the Hp Chek 
were compared with histology and with a reference ELBA. 
MATERIALS AND METHODS 
Patient population 
This study was conducted at 10 geographically diverse 
sites in the United States. Study sites included seven com- 
munity gastroenterologists’ offices, two university medical 
centers, and one VA Medical Center. Patients undergoing 
upper endoscopy for dyspeptic symptoms were recruited for 
enrollment. Those who had received treatment for H. pylori 
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infection within a year of endoscopy were not eligible for 
this trial. Therapy with proton pump inhibitors, bismuth 
compounds, metronidazole, amoxicillin, or tetracycline 
within 1 month of upper endoscopy also excluded patients 
from enrollment. Patients who had undergone previous gas- 
tric surgery, except oversewing of a perforation, were not 
enrolled in this study. All participants provided written 
informed consent. This protocol was approved by the Insti- 
tutional Review Board at each participating hospital. 
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Study protocol 
At the time of upper endoscopy, all study patients under- 
went gastric mucosal biopsy for histological examination 
(two corpus and two antrum). Biopsy specimens were 
placed in formalin and transported to a centralized location 
(Houston VA Medical Center, Texas) for histological eval- 
uation by a single experienced pathologist using the Genta 
stain ( 13). 
Immediately after upper endoscopy, the patients under- 
went whole blood serology testing with the Hp Chek test 
cassette. For this test, a drop of blood obtained by finger- 
stick was placed directly into the sample well of the test 
cassette. As sample flowed through the blood separation 
device in the cassette, red cells were selectively removed. 
Approximately 1 min after administration of the blood sam- 
ple. the cassette tab was pulled, initiating the test procedure. 
Over the next 9 min, a colored front migrated up the testing 
window, followed by a clear front of wicking reagent. Each 
test cassette also had an internal positive control containing 
immobilized human IgG antibodies to H. pylori. A positive 
control indicated that the test cassette operated properly. 
Test results were read visually and interpreted by the pres- 
ence of one red line (positive control, negative test = 
negative study) or two red lines (positive control. positive 
test = positive study) in the testing window. Operators 
reported that the test was easy to perform and interpret. 
In addition to the fingerstick whole blood serology test. 
the patients donated 15 ml of whole blood by standard 
venipuncture. This whole blood sample was centrifuged 
promptly, and a drop of serum was tested with the Hp Chek 
using a protocol similar to that described above. 
Another aliquot of serum was frozen and sent to the 
clinical laboratory at ChemTrak (Sunnyvale. CA) for testing 
with a reference ELISA (HM-CAP; Enteric Products Inc. 
Stony Brook, NY). Reference ELISA testing was performed 
according to the manufacturer’s package insert by an expe- 
rienced microbiologist. 
Interpretation of data and statistical analmis 
Sensitivity (true positive [TP]/TP + false negative [FN]), 
specificity (true negative [TN]/TN + false positive [FP]). 
positive predictive value (PPV; TP/TP + FP). negative 
predictive value (NPV; TN/TN + FN), and percent agree- 
ment were determined for the Hp Chek with whole blood 
and serum and for the reference ELISA using histology as 
the “gold standard.” Test characteristics were also deter- 
TABLE 1 
Performance Clzaracterisrics of r/ze Hp Chek With Whole Blood or 
Serum and a Reference ELJSA Using Histology as the Gold Standard 
Sensitivity Specificity PPV NPV % Agreement 
Hp Chek 88% 85% 83% 90% 86% 
(Whole blood) 
Hp Chek 88% 84% 82% 89% 86% 
(Serum) 
ELISA* 92% 79% 79% 92% 85% 
Sample consists of 287 patients undergoing upper endoscopy for dys- 
peptic symptoms. PPV = positive predictive value; NPV = negative 
predictive value; % agreement = percentage of patients who had the same 
H. pylori status as established by the Hp Chek or ELISA and histology. 
* HM-CAP: Enteric Products Inc., Stony Brook, NY. 
mined for the Hp Chek with whole blood and serum using 
the reference ELISA as a basis for comparison. Finally, test 
characteristics are also presented for the Hp Chek using 
whole blood when discrepent histology results were re- 
solved with the reference ELISA. Test characteristics were 
compared for statistically significant differences using a 
2-way analysis of variance. 
RESULTS 
Patient characteristics 
Two hundred eighty-seven patients (140 women and 147 
men: mean age 53 + 6 yr) enrolled in this trial. The study 
population was 72% white, 14% Hispanic, 11% African 
American, 2% Asian, and 1% other. Histological evidence 
of H. pylori infection was found in 131 patients (46%). 
Hp Chek test characteristics 
When the Hp Chek used with whole blood was compared 
with histology as a gold standard, the sensitivity was 88%, 
specificity 85%, PPV 83%, NPV 90%, and percent agree- 
ment 86% (Table 1). The Hp Chek with serum produced 
similar values for sensitivity, specificity, PPV, NPV, and 
percent agreement of 88%, 84%. 82%, 89%, and 86%. 
respectively. Corresponding values for sensitivity, specific- 
ity. PPV. NPV, and percent agreement with the reference 
ELISA using histology as a gold standard were 92%, 79%, 
79%. 92%, and 85%. There were no statistically significant 
differences among the test characteristics obtained with the 
Hp Chek using whole blood, the Hp Chek using serum, or 
the reference ELISA. 
When the reference ELISA was used as the gold standard, 
the Hp Chek performed with whole blood had a sensitivity of 
87%, specificity of 95%, PPV of 95%, NPV of 87%, and 
overall agreement of 9 1%. Test characteristics of the Hp Chek 
using whole blood and serum relative to the reference ELISA 
are presented in Table 2. Agreement between Hp Chek results 
obtained from whole blood versus serum was 97%. 
When discrepant results with histology were resolved 
using ELISA, test characteristics of the Hp Chek using 
whole blood improved to a sensitivity of 93%, specificity of 
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TABLE 2 
Perfomance Characteristics of the HI, Chek With Whole Blood or 
Serum Using Reference ELISA as a Basis for Comparison 
Sensitivity Specificity PPV NPV % Agreement 
Hp Chek 87% 95% 95% 87% 91% 
(Whole blood) 
Hp Chek 87% 95% 95% 87% 91% 
(Serum) 
Sample consists of 287 patients undergoing upper endoscopy for dys- 
peptic symptoms. PPV = positive predictive value; NPV = negative 
predictive value: 8 agreement = percentage of patients who had the same 
H. pdori status as established by the Hp Chek and ELISA. 
98%, PPV of 98%, NPV of 93%, and overall agreement of 
95%. 
DISCUSSION 
In this age of cost consciousness and practice guidelines, 
the management of patients with dyspeptic symptoms and 
no warning signs (such as advanced age, weight loss, evi- 
dence of bleeding or anemia, or progressive, unrelenting 
symptoms) continues to be a topic of heated debate. Using 
decision analytical modeling, some investigators have sug- 
gested that it would be most cost-effective to treat this 
population empirically for H. pylori infection (3). However, 
it is clear that such a strategy would lead to the unnecessary 
treatment of the majority of dyspeptic patients, as <50% are 
infected with the organism (14, 15). In addition, some of the 
presumptions necessary for such decision analytical model- 
ing were made before the availability of inexpensive, office- 
based serology kits to detect H. pylori infection. The intro- 
duction of such tests could have a profound influence on the 
cost-benefit ratio of identifying infected patients before ini- 
tiating therapy, particularly in the primary care setting. 
Recently, several manufacturers have introduced rapid, 
office-based serology tests that can be performed using 
whole blood. There is no dispute regarding the convenience 
of these tests, However, the published literature addressing 
the performance characteristics of these tests has yielded 
inconsistent results (9-l 2). We report the test characteristics 
of a new fingerstick whole blood serology test, the 
ChemTrak Hp Chek. The Hp Chek relies upon the principle 
of immunochromatography to identify specific IgG antibod- 
ies to H. pylori. The Hp Chek proved easy to perform and 
yielded a positive or negative result within 10 min of inoc- 
ulation with whole blood or serum. 
Using histology as a basis for comparison, the Hp Chek 
yielded a sensitivity, specificity, PPV, and NPV comparable 
to those of a reference ELISA. Test characteristics of the Hp 
Chek were at least equivalent and arguably superior to those 
of other rapid, whole blood serology tests evaluated in 
recent studies (9-12). Agreement between results obtained 
with the Hp Chek using whole blood versus serum was 97%. 
suggesting that these two means of performing the test are 
interchangeable. In addition, we believe that the ethnic and 
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geographical diversity of the patient population studied 
makes our observations that much more credible. Given the 
heterogeneity in H. pylori strains (16) and differences in the 
prevalence of infection among patient populations (17), one 
wonders whether a lack of ethnic and geographical diversity 
may explain, at least in part, the discrepant results found in 
previous studies evaluating other whole blood serology 
tests. 
We used histology as the gold standard for this protocol. 
This method of identifying H. pyfori infection is certainly 
not infallible. It is clear that the histological diagnosis of H. 
pylori infection can be negatively influenced by a lack of 
experience on the part of the interpreting pathologist, the 
recent use of various drugs (including antibiotics, bismuth- 
containing compounds, and proton pump inhibitors), and the 
protocol used to obtain gastric mucosal biopsy specimens 
(1). We attempted to address each of these variables in the 
study protocol. First, histological examination was per- 
formed by a single experienced pathologist using the Genta 
stain (13). Second, we excluded patients treated for H. 
pylori within a year of endoscopy and those recently treated 
with antibiotics or proton pump inhibitors. Finally, we used 
a standardized biopsy protocol, which included obtaining 
two biopsy specimens from both the corpus and antrum in 
each patient at all study sites. Given these precautions, the 
literature suggests that the sensitivity and specificity of 
histology would approach or exceed 95% (1, 18, 19). 
In conclusion, the Hp Chek is a rapid, easy-to-perform 
serology test that can be used to examine whole blood or 
serum for the presence of IgG antibodies to H. pylori. The 
Hp Chek achieved test characteristics similar to those ob- 
served with a reference ELISA. This test should provide an 
accurate means of screening symptomatic patients for H. 
pylori infection in the office setting. 
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